Currently out of the existing stock ratings of Brian Cheng, 111 are a BUY (83.46%), 6 are a SELL (4.51%), 16 are a HOLD (12.03%).
Analyst Brian Cheng, currently employed at JPMORGAN, has had 46.23% of price targets met with an average potential upside of 22.25%, reached in 107 days on average.
Brian Cheng has documented 252 price targets and ratings displayed on 34 stocks. The coverage is on Healthcare, Utilities sectors.
Most recent stock forecast was given on XNCR, Xencor at 03-Sep-2026.
Analyst best performing recommendations are on CRGX (CARGO THERAPEUTICS).
The best stock recommendation documented was for PTGX (PROTAGONIST THERAPEUTICS) on 3/4/2025. The price target of $57 was fulfilled within 7 days with a profit of $18.34 (47.44%), with a performance score of 67.77.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Aug-2024
$19
$10.64 (127.27%)
$17
1 months 6 days ago
(09-Oct-2026)
0/5 (0%)
$5.26 (38.28%)
Buy Since 28-Jan-2025
$20
$11.64 (139.23%)
$23
1 months 22 days ago
(24-Sep-2026)
0/4 (0%)
$5.88 (41.64%)
Hold Since 12-Nov-2025
$20
$11.64 (139.23%)
$8
1 months 22 days ago
(24-Sep-2026)
7/14 (50%)
$5.88 (41.64%)
142
Buy Since 02-Jul-2026
$27
$13.15 (94.95%)
4 months 13 days ago
(02-Jul-2026)
0/1 (0%)
$19.72 (270.88%)
Hold Since 18-Mar-2026
$22
$13.64 (163.16%)
$23
7 months 28 days ago
(18-Mar-2026)
8/11 (72.73%)
$15.45 (235.88%)
99
Which stock is Brian Cheng most bullish on?
Which stock is Brian Cheng most reserved on?
What Year was the first public recommendation made by Brian Cheng?
